Market Access Platform
The industry-leading technology platform that provides exquisite detail and depth across three domains of data—reimbursement, clinical trials, and regulatory—the Market Access Platform (MAP) is the perfect complement to GMAS.
Showcasing the links between regulatory labels and reimbursement with clinical trial design, the MAP uniquely offers:
- An in-depth focus on clinical trials populations and endpoints
- Regulatory labels and approvals (FDA, EMA, Health Canada, TGA)
- English-language translations of HTA decision documents and accessibility to source documents at any time with options to download documents
- A searchable, comparable, unified data model that integrates HTA decision criteria with regulatory approval decisions and expansions to clinical trial endpoint and subpopulation selections.
- A dynamic user experience which provides depth and breadth simultaneous to the users.